CVS Health is reportedly closing down a number of its pharmacies installed in Target stores in the United States. The pharmacies are expected to be removed from the discount department store chain’s locations in early 2024.
As per CNN Business, the spokesperson of CVS Health confirmed the closure of its drug stores on Thursday, Jan. 11. It was said that the decision to stop its operations inside the Target outlets comes as retail pharmacy companies in the U.S. are faced with growing difficulties with their workforce, prescriptions business, and other aspects.
Schedule of the Pharmacy Shut Downs
The American retail pharmacy brand said it will close its stores in Target locations from next month until April this year. The company also said this is part of its strategy to spread out its stores and pharmacies even more. This information was shared with CNN through an email from CVS Pharmacy’s spokesperson, Amy Thibault.
The closing of the pharmacies is “based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients,” the spokeswoman said.
Select Locations are Affected
Forbes reported that only select locations of Target stores are losing their CVS Health outlets this year. Then again, the company did not mention specific locations for the shutdown. The company is currently operating around 9,000 stores across the country.
“The pharmacy closures will begin in February and be completed by the end of April and impacted employees will be offered comparable roles within the company,” CVS Health said in a statement. “The closures are part of our plan to realign our national retail footprint and reduce store and pharmacy density and are based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients.”
Photo by: Marques Thomas/Unsplash


DeepSeek Eyes $74 Billion Valuation Ahead of Planned China IPO
Judge Approves Anthropic’s $1.5 Billion AI Copyright Settlement With Authors
Foxconn Wins First SpaceX AI Server Contract Worth Estimated $52 Billion
GameStop Raises eBay Stake to 9.8% as Ryan Cohen Pushes $56 Billion Takeover Bid
Tesla Stock Outlook: Strong EV Sales Boost Earnings, but AI Projects Drive Long-Term Value
Samsung Cuts U.S. Consumer Electronics Jobs as Headquarters Moves to Texas
Ryanair Warns Summer Airfares May Stay Lower as Quarterly Profit Misses Estimates
Samsung Biologics Launches $1.81 Billion Bid to Acquire PolyPeptide
Belimo H1 Sales Surge as AI Data Center Cooling Drives More Than Half of Growth
Bank of America Says These Overlooked AI Stocks Could Be the Next Winners
ASML Trillion-Dollar Valuation: Can Europe’s AI Chip Giant Reach the Historic Milestone?
Lockheed Martin Unveils Lower-Cost Patriot ACE Interceptor to Meet Rising Air Defense Demand
Trump Criticizes ABC, NBC and CNN for Limiting Coverage of Election Speech
Mikron H1 2026 Sales Fall 5.9% as Automation Weakness Weighs on Profit
KKR, AEW Seek China Property Sales as Commercial Real Estate Slump Deepens
South Korea’s Coupang Fine Sparks U.S. Criticism, Raising Concerns Over Bilateral Ties 



